Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
American Coastal Insurance
ACIC
$486M
| $82.6K | ﹤0.01% |
9,139
+6,112
| +202% | +$60.9K |
2023 Q2
13 quarters
|
|
4327
Kolibri Global Energy
KGEI
$194M
| $82.4K | ﹤0.01% |
13,326
+7,263
| +120% | +$41.6K |
2023 Q4
11 quarters
|
|
4328
US Gold Corp
USAU
$191M
| $82.3K | ﹤0.01% |
5,538
+3,147
| +132% | +$47.5K |
2025 Q2
5 quarters
|
|
4329
Claritev Corp
CTEV
$498M
| $81.8K | ﹤0.01% |
3,862
-7,696
| -67% | -$242K |
2025 Q2
5 quarters
|
|
4330
Copa Holdings
CPA
$6.06B
| $81.7K | ﹤0.01% |
620
| – | – |
2026 Q2
1 quarter
|
|
4331
BridgeBio Oncology
BBOT
$193M
| $81.7K | ﹤0.01% |
19,924
+17,825
| +849% | +$139K |
2026 Q1
2 quarters
|
|
4332
CALL
Kinder Morgan
KMI
$70.3B
| $81.4K | ﹤0.01% |
+2,700
| New | +$85.6K |
2026 Q3
0 quarters
|
|
4333
Alpha Teknova
TKNO
$549M
| $80.9K | ﹤0.01% |
9,094
+2,977
| +49% | +$19.8K |
2024 Q4
7 quarters
|
|
4334
Firy Inc
FIRY
$216M
| $80.6K | ﹤0.01% |
6,503
+4,006
| +160% | +$39.6K |
2025 Q3
4 quarters
|
|
4335
Once Upon a Farm PBC
OFRM
$429M
| $80.5K | ﹤0.01% |
5,111
+1,101
| +27% | +$18.9K |
2026 Q1
2 quarters
|
|
4336
CALL
American Airlines Group
AAL
$9.36B
| $80.2K | ﹤0.01% |
+6,000
| New | +$87.5K |
2026 Q3
0 quarters
|
|
4337
loanDepot
LDI
$159M
| $80.2K | ﹤0.01% |
135,720
+29,749
| +28% | +$27.5K |
2025 Q2
5 quarters
|
|
4338
Ares Commercial Real Estate
ACRE
$201M
| $80.1K | ﹤0.01% |
20,869
+12,392
| +146% | +$55.8K |
2016 Q2
41 quarters
|
|
4339
Limoneira
LMNR
$189M
| $80K | ﹤0.01% |
6,720
+4,227
| +170% | +$56.9K |
2022 Q3
16 quarters
|
|
4340
Hudson Technologies
HDSN
$189M
| $79.7K | ﹤0.01% |
15,482
+9,670
| +166% | +$55.1K |
2022 Q2
17 quarters
|
|
4341
Taylor Devices
TAYD
$189M
| $79.5K | ﹤0.01% |
1,303
+646
| +98% | +$37.1K |
2024 Q2
9 quarters
|
|
4342
NeoVolta
NEOV
$170M
| $79.3K | ﹤0.01% |
30,517
+30,508
| +338,978% | +$89.6K |
2025 Q4
3 quarters
|
|
4343
Palisade Bio
PALI
$199M
| $79.3K | ﹤0.01% |
58,743
+22,490
| +62% | +$43.9K |
2025 Q4
3 quarters
|
|
4344
Eastern Company
EML
$191M
| $78.7K | ﹤0.01% |
3,299
+3,082
| +1,420% | +$78.4K |
2024 Q2
9 quarters
|
|
4345
GoPro
GPRO
$133M
| $78.5K | ﹤0.01% |
60,839
-107,332
| -64% | -$97.4K |
2014 Q3
48 quarters
|
|
4346
Exagen
XGN
$124M
| $78.3K | ﹤0.01% |
9,627
+4,134
| +75% | +$26.6K |
2022 Q1
18 quarters
|
|
4347
Maui Land & Pineapple Co
MLP
$297M
| $77.9K | ﹤0.01% |
4,887
+4,078
| +504% | +$67.2K |
2019 Q1
30 quarters
|
|
4348
SmartRent
SMRT
$323M
| $77.7K | ﹤0.01% |
65,813
+21,215
| +48% | +$25.3K |
2022 Q2
17 quarters
|
|
4349
RGC Resources
RGCO
$234M
| $77.5K | ﹤0.01% |
3,644
+2,189
| +150% | +$48.7K |
2022 Q3
16 quarters
|
|
4350
Cartesian Therapeutics
RNAC
$214M
| $77.2K | ﹤0.01% |
10,706
+5,982
| +127% | +$52.1K |
2019 Q4
27 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.